QZQingqing Zhou

Qingqing Zhou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qingqing Zhou has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perspectives on the small ribonucleic acid drugs for pancreatic cancer

    by Qingqing Zhou, Guoan Shen, Huaying Li, Haimei Chen, Chang Liu

    Pancreatic cancer (PC) remains one of the most lethal forms of cancer. Unfortunately, existing drugs for PC would cause significant side effects, and the tumor may develop resistance to these treatments. Therefore, there is an urgent need to develop new drugs to provide more treatment options for PC patients. Compared to traditional protein-targeted and DNA-based drugs, ribonucleic acid (RNA)-based therapies have gained significant attention in recent years due to their unique physicochemical and physiological properties. Various strategies have been developed to enhance the metabolic stability and intracellular delivery of small RNA drugs, making them a key focus in cancer drug development in recent years. To explore the therapeutic potential of small RNA drugs in PC, an overview of the status of small RNA drug development is provided, including 17 approved small RNA drugs and 43 small RNA drug candidates in clinical trials. In addition, genetic factors involved in PC progression are examined, identifying 17 protein-coding genes and 15 microRNA genes. Finally, six strategies for developing small RNA drugs for PC are discussed.

  • Multiple configurations of the plastid and mitochondrial genomes of Caragana spinosa

    by Qingqing Zhou, Yang Ni, Jingling Li, Linfang Huang, Husheng Li, Haimei Chen, Chang Liu

    Main Conclusion In this study, we assembled the complete plastome and mitogenome of Caragana spinosa and explored the multiple configurations of the organelle genomes. Abstract Caragana spinosa belongs to the Papilionoidea subfamily and has significant pharmaceutical value. To explore the possible interaction between the organelle genomes, we assembled and analyzed the plastome and mitogenome of C. spinosa using the Illumina and Nanopore DNA sequencing data. The plastome of C. spinosa was 129,995 bp belonging to the inverted repeat lacking clade (IRLC), which contained 77 protein-coding genes, 29 tRNA genes, and four rRNA genes. The mitogenome was 378,373 bp long and encoded 54 unique genes, including 33 protein-coding, three ribosomal RNA (rRNA), and 18 transfer RNA (tRNA) genes. In addition to the single circular conformation, alternative conformations mediated by one and four repetitive sequences in the plastome and mitogenome were identified and validated, respectively. The inverted repeat (PDR12, the 12th dispersed repeat sequence in C. spinosa plastome) of plastome mediating recombinant was conserved in the genus Caragana. Furthermore, we identified 14 homologous fragments by comparing the sequences of mitogenome and plastome, including eight complete tRNA genes. A phylogenetic analysis of protein-coding genes extracted from the plastid and mitochondrial genomes revealed congruent topologies. Analyses of sequence divergence found one intergenic region, trnN-GUU-ycf1, exhibiting a high degree of variation, which can be used to develop novel molecular markers to distinguish the nine Caragana species accurately. This plastome and mitogenome of C. spinosa could provide critical information for the molecular breeding of C. spinosa and be used as a reference genome for other species of Caragana. In this study, we assembled the complete plastome and mitogenome of Caragana spinosa and explored the multiple configurations of the organelle genomes. Graphical abstract